Physician profile
Anne Rushing
NPI 1639525207
$1,649.63
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $850 · 2022: $768 · 2023: $30.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.35 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $146.34 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $137.90 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.51 | 2021-2022 | |
| Pfizer INC. | $113.41 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $109.21 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $101.63 | 2022 | |
| Glaxosmithkline, LLC. | $91.22 | 2021-2022 | |
| Novo Nordisk INC | $76.17 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $67.94 | 2022 | |
| Eisai INC. | $59.11 | 2021 | |
| Abbott Laboratories | $54.91 | 2021-2022 | |
| Lilly USA, LLC | $51.18 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.01 | 2021 | |
| Merck Sharp & Dohme LLC | $34.97 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $33.66 | 2022 | |
| Boston Scientific Corporation | $30.97 | 2023 | Watchman Access System |
| Philips North America LLC | $30.14 | 2021 | |
| Esperion Therapeutics, INC. | $29.73 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $18.69 | 2022 | |
| Dynavax Technologies Corporation | $17.86 | 2022 | |
| Dexcom, INC. | $16.58 | 2021 | |
| Alfasigma USA, INC. | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Rushing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.